EURONEXT:ALVIO
Valerio Therapeutics Société anonyme
- Stock
locale
Francemarket
STOCKSindustry
Biotechnologywebsite
valeriotx.comipo date
Jun 05, 2023
Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. The company offers Beleodaq for the treatment of peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for trea...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus